1. Iuchi T, Saeki N, Tanaka M, Sunami K, Yamaura A. MRI prediction of fibrous pituitary adenomas. Acta Neurochir (Wien). 1998. 140:779–786.
2. Snow RB, Johnson CE, Morgello S, Lavyne MH, Patterson RH Jr. Is magnetic resonance imaging useful in guiding the operative approach to large pituitary tumors? Neurosurgery. 1990. 26:801–803.
3. Naganuma H, Satoh E, Nukui H. Technical considerations of transsphenoidal removal of fibrous pituitary adenomas and evaluation of collagen content and subtype in the adenomas. Neurol Med Chir (Tokyo). 2002. 42:202–212. discussion 213.
4. Bahuleyan B, Raghuram L, Rajshekhar V, Chacko AG. To assess the ability of MRI to predict consistency of pituitary macroadenomas. Br J Neurosurg. 2006. 20:324–326.
5. Chakrabortty S, Oi S, Yamaguchi M, Tamaki N, Matsumoto S. Growth hormone-producing pituitary adenomas: MR characteristics and pre- and postoperative evaluation. Neurol Med Chir (Tokyo). 1993. 33:81–85.
6. Hagiwara A, Inoue Y, Wakasa K, Haba T, Tashiro T, Miyamoto T. Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation. Radiology. 2003. 228:533–538.
7. Yamaguchi N, Kawase T, Sagoh M, Ohira T, Shiga H, Toya S. Prediction of consistency of meningiomas with preoperative magnetic resonance imaging. Surg Neurol. 1997. 48:579–583.
8. Suzuki Y, Sugimoto T, Shibuya M, Sugita K, Patel SJ. Meningiomas: correlation between MRI characteristics and operative findings including consistency. Acta Neurochir (Wien). 1994. 129:39–46.
9. Maiuri F, Iaconetta G, de Divitiis O, Cirillo S, Di Salle F, De Caro ML. Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol. 1999. 31:69–75.
10. Yrjana SK, Tuominen H, Karttunen A, Lahdesluoma N, Heikkinen E, Koivukangas J. Low-field MR imaging of meningiomas including dynamic contrast enhancement study: evaluation of surgical and histopathologic characteristics. AJNR Am J Neuroradiol. 2006. 27:2128–2134.
11. Kashimura H, Inoue T, Ogasawara K, et al. Prediction of meningioma consistency using fractional anisotropy value measured by magnetic resonance imaging. J Neurosurg. 2007. 107:784–787.
12. Pierallini A, Caramia F, Falcone C, et al. Pituitary macroadenomas: preoperative evaluation of consistency with diffusionweighted MR imaging--initial experience. Radiology. 2006. 239:223–231.
13. Suzuki C, Maeda M, Hori K, et al. Apparent diffusion coefficient of pituitary macroadenoma evaluated with line-scan diffusion-weighted imaging. J Neuroradiol. 2007. 34:228–235.
14. Mahmoud OM, Tominaga A, Amatya VJ, et al. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur J Radiol. 2010. (Epub ahead of print).
15. Kono K, Inoue Y, Nakayama K, et al. The role of diffusionweighted imaging in patients with brain tumors. AJNR Am J Neuroradiol. 2001. 22:1081–1088.
16. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 2002. 224:177–183.
17. Gudbjartsson H, Maier SE, Mulkern RV, Morocz IA, Patz S, Jolesz FA. Line scan diffusion imaging. Magn Reson Med. 1996. 36:509–519.
18. Pipe JG, Farthing VG, Forbes KP. Multishot diffusion-weighted FSE using PROPELLER MRI. Magn Reson Med. 2002. 47:42–52.